About Journal
BioImpacts   ISSN: 2228-5652 ; eISSN: 2228-5660
Where biological impacts are presented for biomedical and pharmaceutical scientists - Integrative Researches for Translational Medicines.
The BioImpacts (BI), which was founded by Prof. Y. Omidi in 2011, publishes timely, peer-reviewed papers on current topics important to biomedical/pharmaceutical scientists/researchers. BI papers cover a wide range of topics, including contemporary issues in biological (in vitro and in vivo) impacts of advanced and futuristic intervention at molecular, cellular, and in vivo dimensions. 

• CiteScore 2022: 5.2
• SJR 2023: 0.55
• Impact Factor 2023: 2.6
• 5-year Impact Factor: 3.6
• Frequency: Annually (continuous)  since 2025
•  Publisher: Tabriz University of Medical Sciences
•  Acceptance Rate (2024): 20%

Article Types

Editorial; Reviews; Original research; Short communication; Spotlight; Perspective; Commentary; Lessons learned; Scientific analysis  Letter; Research education

Readership 
The journal's insights make it an attractive platform for professional multidisciplinary scientists such as cellular and molecular biologists, pharmacologists, biomedical technologist, pharmaceutical scientists, biological chemists, experimental biologists, geneticists, neuroscientists, biochemists, physiologists, biomedical researchers, translational scientists, and related clinicians.